Navigation Links
Mercy Ships and MediSend International Partner to Deliver Hope and Healing
Date:12/1/2009

p> About Mercy Ships
Mercy Ships uses hospital ships to deliver free, world-class health care services to those without access in the developing world. Founded in 1978 by Don and Deyon Stephens, Mercy Ships has worked in more than 70 countries, providing services valued at more than $748 million, directly impacting more than 2.16 million beneficiaries. More than 1200 crew worldwide, representing more than 40 nations, are joined each year by 2000 short-term volunteers. Professionals including surgeons, dentists, nurses, health care trainers, teachers, cooks, seamen, engineers, and agriculturalists donate their time and skills to the effort. For more information click on www.mercyships.org

###

Read the full story at http://www.prweb.com/releases/2009/12/prweb3272604.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related biology technology :

1. Orthocrat Announces Successful Implementation of TraumaCad at UPMC Mercy
2. Mercy Medical Center Completes Beta Studies for Integrated Hematology and Automated Diabetes Testing Solution
3. Elekta Contract Provides Sisters of Mercy Health System Access to Leading Radiation Therapy Solutions
4. Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference
5. Public-Private Partnerships Key to Achieving Global Food Security, Says DuPont Leader
6. New research reveals the ancestral populations of India and their relationships to modern groups
7. Astellas Awards Educational Scholarships to Six Transplant Recipients Who Embody the Spirit of Giving Back
8. Essilor: Essilor Forges New Strategic Partnerships Around the World
9. New Leadership Team at International Trachoma Initiative to Build Stronger Partnerships to Eliminate Blinding Trachoma
10. Air Force Chief Master Sergeant Rod McKinley (U.S. Air Force Retired) Joins MicroTech as Vice President of Strategic Partnerships
11. Scotland Highlights New Partnerships and Cutting-Edge Drug Discovery Research
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Mercy Ships and MediSend International Partner to Deliver Hope and Healing
(Date:12/19/2014)... NEW YORK , Dec. 18, 2014 ... novel therapies for the treatment of chronic pain, announced ... held today. "This was a transformational year ... a promising future for our company," said Sergio ... past year, we have executed on key financial, human ...
(Date:12/17/2014)... December 17, 2014 Ipsen Biopharmaceuticals, ... IPN; ADR: IPSEY), today announced that ... as Somatuline®) was approved by the U.S. Food ... gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in adult patients with ... metastatic disease to improve progression-free survival (PFS). , ...
(Date:12/17/2014)... Audacity, a leading California-based health and ... the Huntsworth Health Group, is proud to announce the ... her role, Gonzales will serve as Senior Vice President ... to welcome a talent of Jamie’s caliber to the ... “She is a proven healthcare innovation leader and brand ...
(Date:12/17/2014)... Mass. , Dec. 17, 2014   Synageva ... biopharmaceutical company developing therapeutic products for rare disorders, announced ... Conference being held in San Francisco, CA. ... President and Chief Executive Officer, will present on Monday, ... EST).  The presentation will be webcast live and may ...
Breaking Biology Technology:Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8Audacity Welcomes Healthcare Communications Expert Jamie Gonzales as Senior Vice President of Client Services 2
... of the ribosome, the cell,s protein-building machinery, sheds light ... life and suggests that differences in ribosomal structure between ... fossils" of the early evolution of protein synthesis. ... of Illinois, reveals that key regions of the ribosome ...
... VNUS(R) Medical,Technologies, Inc. (Nasdaq: VNUS ) ... year 2008 guidance. The Company has recorded adjustments,to ... sheet accounts,to record additional expenses related to stock-based ... since the adoption of Statement,of Financial Accounting Standard ...
... Brand Strength and Pediatric ... ... Pa., Aug. 18 /Xinhua-PRNewswire-FirstCall/ -- BMP,Sunstone Corporation (Nasdaq: BJGP; "BMP ... Ltd.,("Sunstone"), its wholly-owned subsidiary, has received a production,license from the ...
Cached Biology Technology:Molecular sleuths track evolution through the ribosome 2Molecular sleuths track evolution through the ribosome 3VNUS Corrects Second Quarter 2008 Results and Revises Full Year 2008 Guidance 2VNUS Corrects Second Quarter 2008 Results and Revises Full Year 2008 Guidance 3VNUS Corrects Second Quarter 2008 Results and Revises Full Year 2008 Guidance 4BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC 2BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC 3BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC 4
(Date:12/11/2014)... DUBLIN , Dec. 09, 2014 Research ... http://photos.prnewswire.com/prnh/20130307/600769 ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) ... Market in the APAC Region 2015-2019"  report to ... emerging in this market is advances in technology. ... to upgrade biometric solutions to the latest standard ...
(Date:12/10/2014)... -- Valencell, a leader in performance biometric data sensor technology, ... its licensees for highly accurate, clinically validated biometric technology. ... from fitness and health sectors, but first responders/military and ... only as useful as the biometric data it delivers. ... long-term mass consumer adoption of wearable products," said Dr. ...
(Date:12/5/2014)... Calif. , Dec. 4, 2014 ... has boosted investments in new testing and inspection ... also given rise to a range of innovative ... the requirements of Generation Y, which is generally ... As a result, product development strategies of test ...
Breaking Biology News(10 mins):Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wearable Technology Products Demand Highly Accurate Biometric Technology 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4
... prestigious New England Journal of Medicine (NEJM) shows ... non-drug treatment for asthma, demonstrated an overall improvement ... Gerard Cox, respirologist at St. Joseph’s Healthcare Hamilton’s ... McMaster University, and Dr. John Miller, Division Head ...
... that it has added high-density genotyping on both ... of services. Stan Nelson, the principal investigator at ... its user-base of ~10,000 investigators across the world ... the scientific community." , The Consortium is ...
... provide cystic fibrosis (CF) patients with targeted treatment ... a French clinical trial published today in BMC ... sufferers with a rare genetic stop mutation responded ... Isabelle Sermet-Gaudelus of Faculté de Médicine Necker in ...
Cached Biology News:Groundbreaking Canadian asthma study 2NIH neuroscience microarray consortium launches high-throughput genotyping services 2
...
Rabbit polyclonal to JNK1 (phospho T183 + Y185) ( Abpromise for all tested applications). entrezGeneID: 5599 SwissProtID: P45983...
Permeabilization Solution, 5X...
PCR purification kit, 100 preps...
Biology Products: